Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
VSJ-110 Phase 2 Results Expected
Target Indication
Dry Eye
Clinical Trial
Last updated: 1/2/2026
VNDA
Vanda Pharmaceuticals Inc.
Motion Sickness
Insomnia
Primary Insomnia
Insomnia Disorder
Autism Spectrum Disorder